Cargando…
Targeting dopamine transporter to ameliorate cognitive deficits in Alzheimer's disease
Alzheimer's disease (AD) is characterized by the pathologic deposition of amyloid and neurofibrillary tangles in the brain, leading to neuronal damage and defective synapses. These changes manifest as abnormalities in cognition and behavior. The functional deficits are also attributed to abnorm...
Autores principales: | Shaikh, Ammara, Ahmad, Fairus, Teoh, Seong Lin, Kumar, Jaya, Yahaya, Mohamad Fairuz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679733/ https://www.ncbi.nlm.nih.gov/pubmed/38026688 http://dx.doi.org/10.3389/fncel.2023.1292858 |
Ejemplares similares
-
Honey and Alzheimer’s Disease—Current Understanding and Future Prospects
por: Shaikh, Ammara, et al.
Publicado: (2023) -
Caffeic Acid on Metabolic Syndrome: A Review
por: Muhammad Abdul Kadar, Nellysha Namela, et al.
Publicado: (2021) -
Comparable Benefits of Stingless Bee Honey and Caffeic Acid in Mitigating the Negative Effects of Metabolic Syndrome on the Brain
por: Muhammad Abdul Kadar, Nellysha Namela, et al.
Publicado: (2022) -
Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
por: Husna Ibrahim, Nurul, et al.
Publicado: (2020) -
Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol
por: Threlfell, Sarah, et al.
Publicado: (2021)